Clinical Trial Update: Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ARA 290 for improving corneal nerve fiber density and neuropathic symptoms in subjects with sarcoidosis; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• ARA-290 (ARA-290)

Snippet

Sponsor: Araim Pharmaceuticals, Inc. | Conditions: Neuropathy of Sarcoidosis | Phase 2 | Status: COMPLETED | Results posted: 2017-01-18